دورية أكاديمية
أعرض في EDS

Pulmonary metastasectomy and repeat metastasectomy for colorectal pulmonary metastases: outcomes from the Dutch Lung Cancer Audit for Surgery.

التفاصيل البيبلوغرافية
العنوان: Pulmonary metastasectomy and repeat metastasectomy for colorectal pulmonary metastases: outcomes from the Dutch Lung Cancer Audit for Surgery.
المؤلفون: van Dorp M; Department of Cardiothoracic Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Wolfhagen N; Dutch Institute for Clinical Auditing, Leiden, The Netherlands., Torensma B; Department of Anaesthesiology, Leiden University Medical Centre, Leiden, The Netherlands., Dickhoff C; Department of Cardiothoracic Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Kazemier G; Department of Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Heineman DJ; Department of Cardiothoracic Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Schreurs WH; Department of Surgery, Northwest Clinics, Alkmaar, The Netherlands.
المصدر: BJS open [BJS Open] 2023 May 05; Vol. 7 (3).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101722685 Publication Model: Print Cited Medium: Internet ISSN: 2474-9842 (Electronic) Linking ISSN: 24749842 NLM ISO Abbreviation: BJS Open Subsets: MEDLINE
أسماء مطبوعة: Publication: 2021- : [Oxford] : Oxford University Press
Original Publication: [Chichester, West Sussex, England] : John Wiley & Sons Ltd., [2017]-
مواضيع طبية MeSH: Metastasectomy* , Colorectal Neoplasms*/pathology , Lung Neoplasms*/surgery, Humans ; Prognosis ; Postoperative Complications
مستخلص: Background: Surgical resection of recurrent pulmonary metastases in patients with colorectal cancer is an established treatment option; however, the evidence for repeat resection is limited. The aim of this study was to analyse long-term outcomes from the Dutch Lung Cancer Audit for Surgery.
Methods: Data from the mandatory Dutch Lung Cancer Audit for Surgery were used to analyse all patients after metastasectomy or repeat metastasectomy for colorectal pulmonary metastases from January 2012 to December 2019 in the Netherlands. Kaplan-Meier survival analysis was performed to determine the difference in survival. Multivariable Cox regression analyses were performed to identify predictors of survival.
Results: A total of 1237 patients met the inclusion criteria, of which 127 patients underwent repeat metastasectomy. Five-year overall survival was 53 per cent after pulmonary metastasectomy for colorectal pulmonary metastases and 52 per cent after repeat metastasectomy (P = 0.852). The median follow-up was 42 (range 0-285) months. More patients experienced postoperative complications after repeat metastasectomy compared with the first metastasectomy (18.1 per cent versus 11.6 per cent respectively; P = 0.033). Eastern Cooperative Oncology Group performance status greater than or equal to 1 (HR 1.33, 95 per cent c.i. 1.08 to 1.65; P = 0.008), multiple metastases (HR 1.30, 95 per cent c.i. 1.01 to 1.67; P = 0.038), and bilateral metastases (HR 1.50, 95 per cent c.i. 1.01 to 2.22; P = 0.045) were prognostic factors on multivariable analysis for pulmonary metastasectomy. Diffusing capacity of the lungs for carbon monoxide less than 80 per cent (HR 1.04, 95 per cent c.i. 1.01 to 1.06; P = 0.004) was the only prognostic factor on multivariable analysis for repeat metastasectomy.
Conclusion: This study demonstrates that patients with colorectal pulmonary metastases have comparable median and 5-year overall survival rates after primary or recurrent pulmonary metastasectomy. However, repeat metastasectomy has a higher risk of postoperative complications.
(© The Author(s) 2023. Published by Oxford University Press on behalf of BJS Society Ltd.)
References: Ann Oncol. 2010 Jun;21(6):1285-1289. (PMID: 19861579)
Eur J Surg Oncol. 2021 Mar;47(3 Pt B):649-659. (PMID: 33183927)
Interact Cardiovasc Thorac Surg. 2016 Jun;22(6):826-30. (PMID: 26920721)
Langenbecks Arch Surg. 2017 Feb;402(1):77-85. (PMID: 28058514)
Ann Surg Oncol. 2013 Feb;20(2):572-9. (PMID: 23104709)
Ann Thorac Surg. 2004 Jul;78(1):238-44. (PMID: 15223436)
Ann Thorac Surg. 2007 Jul;84(1):203-10. (PMID: 17588413)
Gen Thorac Cardiovasc Surg. 2010 Oct;58(10):516-23. (PMID: 20941565)
Clin Exp Metastasis. 2020 Dec;37(6):675-682. (PMID: 32920725)
Ann Thorac Surg. 2018 Aug;106(2):421-427. (PMID: 29605599)
Adv Exp Med Biol. 2021;1335:37-44. (PMID: 33890245)
Eur J Cardiothorac Surg. 2020 Oct 1;58(4):768-774. (PMID: 32282876)
Ann Thorac Surg. 2017 Feb;103(2):399-405. (PMID: 27793399)
World J Gastroenterol. 2014 May 28;20(20):6133-45. (PMID: 24876735)
J Thorac Cardiovasc Surg. 2019 Oct;158(4):1234-1241.e16. (PMID: 31395367)
Radiother Oncol. 2022 Feb;167:187-194. (PMID: 34952002)
Eur J Surg Oncol. 2022 Jan;48(1):253-260. (PMID: 34656390)
Ann Thorac Surg. 2009 Jun;87(6):1684-8. (PMID: 19463577)
Eur J Surg Oncol. 2022 May;48(5):1104-1109. (PMID: 34895970)
J Surg Oncol. 2019 Sep;120(4):729-735. (PMID: 31290159)
Ann Surg Oncol. 2013 Jun;20(6):1955-61. (PMID: 23334254)
Thorac Cardiovasc Surg. 2012 Sep;60(6):398-404. (PMID: 22228090)
Ann Thorac Surg. 2007 Jul;84(1):324-38. (PMID: 17588454)
Future Oncol. 2015;11(2 Suppl):37-41. (PMID: 25662327)
Ann Thorac Surg. 2012 Dec;94(6):1802-9. (PMID: 23063195)
J Gastrointest Surg. 2021 Oct;25(10):2637-2648. (PMID: 34031855)
World J Surg Oncol. 2020 Nov 30;18(1):314. (PMID: 33256771)
Ann Thorac Surg. 2018 Aug;106(2):390-397. (PMID: 29689237)
Gen Thorac Cardiovasc Surg. 2020 Oct;68(10):1172-1178. (PMID: 32323124)
World J Surg. 2010 Oct;34(10):2373-8. (PMID: 20582543)
Eur J Cardiothorac Surg. 2021 May 8;59(5):996-1003. (PMID: 33230525)
Prostate Cancer Prostatic Dis. 2000 Dec;3(4):265-268. (PMID: 12497075)
تواريخ الأحداث: Date Created: 20230505 Date Completed: 20230508 Latest Revision: 20230512
رمز التحديث: 20230513
مُعرف محوري في PubMed: PMC10162679
DOI: 10.1093/bjsopen/zrad009
PMID: 37146204
قاعدة البيانات: MEDLINE
الوصف
تدمد:2474-9842
DOI:10.1093/bjsopen/zrad009